Plain-English translation of NCT06059222 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 4 — The treatment has already been approved. Researchers are tracking how it works in a large number of people over time.
This study is testing whether switching between two bone-strengthening medications in a specific pattern works better than other treatment schedules. The trial compares three different ways of giving and over two years to see which one builds bone strength most effectively in postmenopausal women with osteoporosis.
Bone-strengthening medications can help prevent fractures and increase bone density, but they are expensive. This trial wants to find the most efficient treatment schedule that gives the best results while potentially using these medications more wisely.
You likely qualify if…
You likely don't qualify if…
You will be randomly assigned to one of three groups, each receiving different schedules of the two medications over 24 months. Some participants will take one medication for 12 months then switch to another; others will alternate between medications in shorter cycles. You'll visit the clinic regularly for injections and bone density scans to track how well the treatment is working.
AI-generated summary from trial data · Jul 5, 2026 · Not medical advice
Denmark
Post-approval monitoring
Sponsor
University of Aarhus
Enrollment target
~270 participants
Started
October 2023
Primary completion
August 2030
Age range
50 Years and older
Sex
Female only
Last updated on clinicaltrials.gov in July 2026.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Vivi Makinen, MD
Department of Endocrinology and Internal medicin, Aarhus University Hospital
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.